S&P 500   3,254.36 (-1.68%)
DOW   26,312.27 (-1.30%)
QQQ   268.98 (-2.68%)
AAPL   109.11 (-5.39%)
MSFT   201.66 (-1.49%)
FB   264.97 (-5.65%)
GOOGL   1,627.68 (+4.55%)
AMZN   3,050.23 (-5.01%)
TSLA   386.50 (-5.92%)
NVDA   495.80 (-4.83%)
BABA   303.89 (-2.77%)
CGC   18.47 (-1.65%)
GE   7.36 (-0.14%)
MU   49.78 (-1.39%)
AMD   74.81 (-4.11%)
T   26.84 (+0.30%)
F   7.70 (-2.53%)
ACB   3.96 (-3.18%)
GILD   57.60 (-1.59%)
NIO   30.78 (-3.78%)
NFLX   475.91 (-5.61%)
BA   142.59 (-3.84%)
DIS   120.19 (-1.11%)
S&P 500   3,254.36 (-1.68%)
DOW   26,312.27 (-1.30%)
QQQ   268.98 (-2.68%)
AAPL   109.11 (-5.39%)
MSFT   201.66 (-1.49%)
FB   264.97 (-5.65%)
GOOGL   1,627.68 (+4.55%)
AMZN   3,050.23 (-5.01%)
TSLA   386.50 (-5.92%)
NVDA   495.80 (-4.83%)
BABA   303.89 (-2.77%)
CGC   18.47 (-1.65%)
GE   7.36 (-0.14%)
MU   49.78 (-1.39%)
AMD   74.81 (-4.11%)
T   26.84 (+0.30%)
F   7.70 (-2.53%)
ACB   3.96 (-3.18%)
GILD   57.60 (-1.59%)
NIO   30.78 (-3.78%)
NFLX   475.91 (-5.61%)
BA   142.59 (-3.84%)
DIS   120.19 (-1.11%)
S&P 500   3,254.36 (-1.68%)
DOW   26,312.27 (-1.30%)
QQQ   268.98 (-2.68%)
AAPL   109.11 (-5.39%)
MSFT   201.66 (-1.49%)
FB   264.97 (-5.65%)
GOOGL   1,627.68 (+4.55%)
AMZN   3,050.23 (-5.01%)
TSLA   386.50 (-5.92%)
NVDA   495.80 (-4.83%)
BABA   303.89 (-2.77%)
CGC   18.47 (-1.65%)
GE   7.36 (-0.14%)
MU   49.78 (-1.39%)
AMD   74.81 (-4.11%)
T   26.84 (+0.30%)
F   7.70 (-2.53%)
ACB   3.96 (-3.18%)
GILD   57.60 (-1.59%)
NIO   30.78 (-3.78%)
NFLX   475.91 (-5.61%)
BA   142.59 (-3.84%)
DIS   120.19 (-1.11%)
S&P 500   3,254.36 (-1.68%)
DOW   26,312.27 (-1.30%)
QQQ   268.98 (-2.68%)
AAPL   109.11 (-5.39%)
MSFT   201.66 (-1.49%)
FB   264.97 (-5.65%)
GOOGL   1,627.68 (+4.55%)
AMZN   3,050.23 (-5.01%)
TSLA   386.50 (-5.92%)
NVDA   495.80 (-4.83%)
BABA   303.89 (-2.77%)
CGC   18.47 (-1.65%)
GE   7.36 (-0.14%)
MU   49.78 (-1.39%)
AMD   74.81 (-4.11%)
T   26.84 (+0.30%)
F   7.70 (-2.53%)
ACB   3.96 (-3.18%)
GILD   57.60 (-1.59%)
NIO   30.78 (-3.78%)
NFLX   475.91 (-5.61%)
BA   142.59 (-3.84%)
DIS   120.19 (-1.11%)
Log in
NYSE:ZBH

Zimmer Biomet Stock Forecast, Price & News

$132.04
-1.80 (-1.34 %)
(As of 10/30/2020 01:02 PM ET)
Add
Compare
Today's Range
$130.14
Now: $132.04
$134.06
50-Day Range
$132.12
MA: $140.76
$149.15
52-Week Range
$74.37
Now: $132.04
$161.11
Volume14,945 shs
Average Volume1.43 million shs
Market Capitalization$27.34 billion
P/E Ratio825.30
Dividend Yield0.72%
Beta1.34
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and office based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Read More
Zimmer Biomet logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.15 out of 5 stars

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone574-267-6131
Employees19,900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.98 billion
Cash Flow$12.21 per share
Book Value$60.25 per share

Profitability

Net Income$1.13 billion

Miscellaneous

Market Cap$27.34 billion
Next Earnings Date11/6/2020 (Confirmed)
OptionableOptionable
$132.04
-1.80 (-1.34 %)
(As of 10/30/2020 01:02 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

How has Zimmer Biomet's stock price been impacted by COVID-19 (Coronavirus)?

Zimmer Biomet's stock was trading at $111.19 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ZBH shares have increased by 18.2% and is now trading at $131.41.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Zimmer Biomet?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 5 hold ratings, 17 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Zimmer Biomet
.

When is Zimmer Biomet's next earnings date?

Zimmer Biomet is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Zimmer Biomet
.

How can I listen to Zimmer Biomet's earnings call?

Zimmer Biomet will be holding an earnings conference call on Friday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announced its quarterly earnings data on Tuesday, August, 4th. The medical equipment provider reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.72) by $0.77. The medical equipment provider had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $922.16 million. Zimmer Biomet had a net margin of 0.52% and a return on equity of 10.07%. The firm's quarterly revenue was down 38.4% compared to the same quarter last year. During the same period last year, the company posted $1.93 earnings per share.
View Zimmer Biomet's earnings history
.

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Thursday, September 10th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.24 per share on Friday, October 30th. This represents a $0.96 annualized dividend and a dividend yield of 0.73%. The ex-dividend date is Tuesday, September 29th.
View Zimmer Biomet's dividend history
.

What price target have analysts set for ZBH?

25 Wall Street analysts have issued 1 year price targets for Zimmer Biomet's stock. Their forecasts range from $99.00 to $177.00. On average, they anticipate Zimmer Biomet's stock price to reach $151.88 in the next twelve months. This suggests a possible upside of 15.6% from the stock's current price.
View analysts' price targets for Zimmer Biomet
.

Are investors shorting Zimmer Biomet?

Zimmer Biomet saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 2,550,000 shares, a decline of 15.8% from the September 30th total of 3,030,000 shares. Based on an average daily volume of 965,800 shares, the short-interest ratio is currently 2.6 days.
View Zimmer Biomet's Short Interest
.

Who are some of Zimmer Biomet's key competitors?

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), The Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the following people:
  • Mr. Bryan C. Hanson, Pres, CEO & Director (Age 53, Pay $2.88M)
  • Mr. Suketu P. Upadhyay, Exec. VP & CFO (Age 51, Pay $2.2M)
  • Mr. Sang Yi, Pres of Asia Pacific (Age 58, Pay $1.21M)
  • Mr. Didier Deltort, Pres of Europe, Middle East & Africa (Age 53, Pay $1.24M)
  • Mr. Ivan Tornos, Group Pres of Global Bus.es & Americas (Age 44, Pay $1.9M)

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.40%), Focused Investors LLC (0.39%), Douglas Lane & Associates LLC (0.22%), Deroy & Devereaux Private Investment Counsel Inc. (0.07%), State of New Jersey Common Pension Fund D (0.07%) and Heritage Investors Management Corp (0.06%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Michael J Farrell, Michael W Michelson, Sang Yi and Syed A Jafry.
View institutional ownership trends for Zimmer Biomet
.

Which major investors are selling Zimmer Biomet stock?

ZBH stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Xponance Inc., CIBC Private Wealth Group LLC, Focused Investors LLC, Toronto Dominion Bank, Standard Life Aberdeen plc, State of Alaska Department of Revenue, and Boston Trust Walden Corp. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, and Sang Yi.
View insider buying and selling activity for Zimmer Biomet
.

Which major investors are buying Zimmer Biomet stock?

ZBH stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Foundry Partners LLC, Regentatlantic Capital LLC, Cordatus Wealth Management LLC, Douglas Lane & Associates LLC, Rhenman & Partners Asset Management AB, British Airways Pensions Investment Management Ltd, and CWM LLC. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson, and Syed A Jafry.
View insider buying and selling activity for Zimmer Biomet
.

How do I buy shares of Zimmer Biomet?

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $131.41.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $27.21 billion and generates $7.98 billion in revenue each year. The medical equipment provider earns $1.13 billion in net income (profit) each year or $7.87 on an earnings per share basis. Zimmer Biomet employs 19,900 workers across the globe.

What is Zimmer Biomet's official website?

The official website for Zimmer Biomet is www.zimmerbiomet.com.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.